论文部分内容阅读
目的观察低分子肝素钠与灯盏花素治疗老年不稳定型心绞痛的疗效及安全性。方法将76例UAP患者随机分成对照组(常规治疗)和治疗组(低分子肝素+灯盏花素)。结果对照组与治疗组在改善心绞痛临床表现及心电图方面,总有效率分别为71.05%和89.47%,差异有显著性(P<0.05)。治疗组全部耐受治疗,无出血及其他并发症。结论联合应用低分子肝素和灯盏花素是治疗不稳定型心绞痛效果肯定、安全方便的方法。
Objective To observe the efficacy and safety of low molecular weight heparin and breviscapine in the treatment of unstable angina in the elderly. Methods 76 UAP patients were randomly divided into control group (conventional treatment) and treatment group (low molecular weight heparin + breviscapine). Results The total effective rates of the control group and the treatment group in improving clinical manifestations and electrocardiogram of angina were 71.05% and 89.47%, respectively, with significant difference (P <0.05). The treatment group were all tolerated, with no bleeding and other complications. Conclusion The combination of low molecular weight heparin and breviscapine is a safe, convenient and effective method for the treatment of unstable angina pectoris.